Patient with stable ischaemic heart disease and essential thrombocythemia in Invasive Cardiology Laboratory - Role of the automated systems for estimation of platelet aggregation;Chory ze stabilna̧ choroba̧ wieńcowa̧ i współistnieja̧ca̧ nadpłytkowościa̧ samoistna̧ w Pracowni Kardiologii Inwazyjnej - Rola zautomatyzowanych systemów oceny stopnia agregacji płytek

Kardiologia Polska

Volumn 61, Issue 10, 2004, Pages 370-373

  Huczek, Zenon ^a   Filipiak, Krzysztof J ^a   Kochman, Janusz ^a   Horszczaruk, Grzegorz J ^a   Pia̧tkowski, Radosław ^a   Grabowski, Marcin ^a   Karpiński, Grzegorz ^a   Wilczyńska, Joanna ^a   Opolski, Grzegorz ^a  

^a WARSZAWSKI UNIWERSYTET MEDYCZNY   (Poland)

Author keywords

Coronary artery disease; Platelet activity; Platelet function analyser; Thrombocythemia

Indexed keywords

ANTITHROMBOCYTIC AGENT; TIROFIBAN;

ADULT; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CORONARY ARTERY DISEASE; CORONARY STENT; ELECTIVE SURGERY; HEART CATHETERIZATION; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; LABORATORY AUTOMATION; MALE; RIGHT CORONARY ARTERY; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTHEMIA; THROMBOSIS; BLOOD CLOTTING PARAMETERS; CARDIOLOGY; EQUIPMENT DESIGN; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; INFORMATION PROCESSING; INSTRUMENTATION; LABORATORY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

AUTOMATIC DATA PROCESSING; CARDIOLOGY; EQUIPMENT DESIGN; HUMANS; LABORATORIES; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; THROMBOCYTHEMIA, HEMORRHAGIC;

EID: 8444227477     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Fuster V., Badimon L., Badimon J.J. i wsp.: The pathogenesis of coronary artery disease and the acute coronary syndromes. N. Engl. J. Med. 1992, 326 (4), 242-250.
2. Opolski G., Filipiak K.J., Poloński L.: Ostre zespoły wieńcowe. Wyd. Urban&Partner, Wrocław 2002.
3. Trip M.D., Cats V.M., van Capelle F.J. i wsp.: Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N. Engl. J. Med. 1990, 322 (22), 1549-1554.
4. Elwood P.C., Renaud S., Sharp D.S. i wsp.: Ischemic heart disease and platelet aggregation: the Caerphilly collaborative heart disease study. Circulation 1991, 83 (1), 38-44.
5. Pontiggia L., Lassila R., Pederiva S. i wsp.: Increased platelet-collagen interaction associated with double homozygosity for receptor polymorphisms of platelet GPIa and GPIIIa. Arterioscler. Thromb. Vasc. Biol. 2002, 22 (12), 2093-2098.
6. Golanski J., Golanski R., Chizynski K.: Platelet hyperreactivity after coronary artery bypass grafting: the possible relevance to glycoprotein polymorphisms. A preliminary report. Platelets 2001, 12 (4), 241-247.
7. Propping P, Friedl W.: Genetic control of adrenergic receptors on human platelets: a twin study. Hum. Genet. 1983, 64 (2), 105-109.
8. Kritzik M., Savage B., Nugent D.J. i wsp.: Nucleotide polymorphisms in the 2 gene define multiple alleles that are associated with differences in platelet 2 β1 density. Blood 1998, 92 (7), 2382-2388.
9. Kunicki T.J., Kritzik M., Annis D.S. i wsp.: Hereditary variation in platelet integrin 2 β1 density is associated with two silent polymorphisms in the 2 gene coding sequence. Blood 1997, 89 (6), 1939-1943.
10. Watala C., Golanski J., Rozalski M. i wsp.: Is platelet aggregation a more important contributor than platelet adhesion to the overall platelet-related primary haemostasis measured by PFA-100? Throm. Res. 2003, 109 (5-6), 299-306.
11. Fattorutto M.: Measurement of the effect of ticlopidine with the platelet function analyser (PFA-100) during coronary stent implantation. Am. Heart J. 2003, 146 (3), E8.
12. Saleh N., Hansson L.O., Kohut M. i wsp.: Platelet function and myocardial injury during percutaneous coronary intervention. J. Thromb. Thrombolysis. 2002, 13 (2), 69-73.
13. Renda G., Rocca B., Crocchiolo R. i wsp.: Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban. Thromb. Haemost. 2003, 89 (2), 348-354.
14. Madan M., Berkowitz S.D., Christie D.J. i wsp.: Determination of platelet aggregation inhibition during percutaneous coronary intervention with the platelet function analyzer PFA-100. Am. Heart J. 2002, 144 (1), 151-158.
15. Macchi L., Christiaens L., Brabant S.: Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate. Thromb. Res. 2002, 107 (1-2), 45-49.
16. Fujimura M., Akaike M., Kato M. i wsp.: Aggressive antiplatelet therapy before coronary stent implantation in acute coronary syndrome with essential thrombocythemia: a case report. Angiology 2003, 54 (4), 485-490.
17. Kundu S.K., Heilmann E.J., Sio R. i wsp.: Description of an in vitro platelet function analyzer: PFA-100 Semin. Thromb. Hemost. 1995, 21, Suppl 2, 106-112.
18. Golanski J., Chizynski K., Golanski R., Watala C.: Use of platelet function analyzer PFA-100 and whole blood aggregometry to monitor blood platelet sensitivity to acetylsalicylic acid (aspirin). Is it possible to reliably monitor antiplatelet treatment using routine laboratory diagnostic methods? Pol. Arch. Med. Wewn. 2000, 104 (1), 355-361.
19. Rand M.L., Leung R., Packham M.A.: Platelet function assays. Transfus. Apheresis. Sci. 2003, 28 (3), 307-317.
20. Favaloro E.J.: Clinical application of the PFA-100. Curr. Opin. Hematol. 2002, 9 (5), 407-415.